Pay in 4 interest-free payments of $20.00 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Smiles: NC1=CC=CC=C1NC(=O)C1=CN=CC=N1
Epub 2014 May 27
Zimovane D8
PF-4800567 shows inhibitory activity against CK1ϵ and CK1δ in whole cells
the weights of the placentas are significantly reduced after 0
Bardoxolone (methyl) noprofen Smiles: NC1=CC=CC=C1NC(=O)C1=CN=CC=N1Bardoxolone methyl (also known as RTA 402 and CDDO methyl ester) is an orally available first in class synthetic triterpenoid belonging to the antioxidant inflammation modulator (AIM) class. It is the most potent known inducer of the Nrf2 pathway to enter clinical development and works to suppress both oxidative stress and inflammation. Bardoxolone methyl is currently being developed by Reata Pharmaceuticals, Inc. in partnership with Abbott
US$ 297.50
US$ 497.50
US$ 497.50
US$ 497.50
US$ 160.81
US$ 497.50
US$ 197.50
US$ 497.50
US$ 697.50
US$ 772.50
US$ 497.50
US$ 297.50